In December 2023, one Biologics company received an FDA inspection in Connecticut, according to the U.S. Food and Drug Administration (FDA).
This was the lowest number of inspections per type of company made by the FDA in Connecticut, equalling 25% of all inspections in December 2023.
The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.
The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 1 | — | — |
| Colors and Cosmetics Technology | 1 | — | — |
| Compliance: Devices | 2 | — | — |
| Human Cellular, Tissue, and Gene Therapies | 1 | — | — |
| Postmarket Assurance: Devices | 2 | — | — |
